Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to FDA-Approved TRULANCE® from Synergy Pharmaceuticals

Stock Information for Cipher Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results
Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call
Cipher Pharmaceuticals Announces the Commencement of OTCQX Trading
OTC Markets Group Welcomes Cipher Pharmaceuticals Inc. to OTCQX
Cipher Pharmaceuticals Announces Change of Auditor
Cipher Pharmaceuticals Announces Normal Course Issuer Bid
Cipher Pharmaceuticals Reports Strong Sales & Earnings Growth in Q3 2023

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.